Showing results (581-590 of 1,039) with videos related to

Sort By:
Pageof 104
Environmental Science & Technology|July 21, 2025
Techno-Economic Analysis and Life Cycle Assessment of Alternative Fuels for Locomotives in the U.S. Freight Rail SectorTai-Yuan Huang, Farhad H Masum, Yuan Jiang, et al.
World Neurosurgery|November 26, 2022
Immunohistochemical Profiling and Staging in Esthesioneuroblastoma: A Single-Center Cohort Study and Systematic ReviewJ Curran Henson, Chris C Cutler, Kyril L Cole, et al.
Journal of Applied Clinical Medical Physics|August 19, 2010
Dosimetric performance of the new high-definition multileaf collimator for intracranial stereotactic radiosurgeryAnees Dhabaan, Eric Elder, Eduard Schreibmann, et al.
Journal of Neuro-Oncology|February 27, 2013
Clinical outcomes for a novel 6 degrees of freedom image guided localization method for frameless radiosurgery for intracranial brain metastasesRoshan S Prabhu, Anees Dhabaan, William A Hall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiformeJ Del Rowe, C Scott, M Werner-Wasik, et al.
Molecular Cancer Therapeutics|November 8, 2011
Rapamycin induces Bad phosphorylation in association with its resistance to human lung cancer cellsYan Liu, Shi-Yong Sun, Taofeek K Owonikoko, et al.
Medical Physics|November 6, 2014
Prostate CT segmentation method based on nonrigid registration in ultrasound-guided CT-based HDR prostate brachytherapyXiaofeng Yang, Peter Rossi, Tomi Ogunleye, et al.
Radiation Oncology (London, England)|February 18, 2011
Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinomaXinglei Shen, Albert Denittis, Maria Werner-Wasik, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 1999
A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant gliomaR S Hudes, B W Corn, M Werner-Wasik, et al.
Pageof 104